NO BASE PAY INCREASE IN 2014!!!!!!!!

Discussion in 'Eli Lilly' started by Anonymous, Jul 17, 2013 at 9:56 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Yes, anyone who reads the news can see that the G20 (including China and Europe) are now going after global accounting fraud which artificially inflates profits at the expense of global taxpayers. Shame shame shame.... I can hear the shredders working overtime... the IT staff in India reformatting whole servers.... the PM system deleting honest ... the list goes on and on.
     

  2. Anonymous

    Anonymous Guest

    Cialis is a biological?

    Must have missed that memo.

    Again I repeat.....if the biologicals in the pipeline are as bad as many around here state then why is the co building new biological manufacturing facilities in Europe?

    You don't build unless you are confident of having something to manufacture.

    And I don't agree that the reason for doing so is for creative accounting to mislead investors.
     
  3. Anonymous

    Anonymous Guest

    Remember something called Beirsdorf/LLY? No, neither do the people who were canned there. BEAUTIFUL new facility, open long enough to occupy, lay everyone off, then shut down. Remember MSG? Hmmm.... No? Ask the folks in San Diego how secure they're feeling now days... folks from LCC transferred there for the sole purpose to SHUT IT DOWN in the next 18 months. Keep drinking your Fool-Ade, son.
     
  4. Anonymous

    Anonymous Guest

    Right on the mark. This is exactly what is happening in San Diego. Yep. MSG. Wonderful facility. Kerpow! Gone. Same things happening even at LTC now. Whole areas unoccupied. It is getting more deserted as time goes by.
     
  5. Anonymous

    Anonymous Guest

    I find it interesting that Elanco is having to take the same crap as the rest of the company. They have a different bonus system there and have had better bonuses than LLY schmucks.
     
  6. Anonymous

    Anonymous Guest

    Difference with Indy facilities is that they need to be kept open (with or without people) to get some sweetheart tax breaks no doubt.

    Anyone hazard to guess how many billions have been poured into China prior to the recent govt price-fixing there. Kerpow! There goes your projected global growth.
     
  7. Anonymous

    Anonymous Guest

    Yeah this sounds a lot like what happened with Sphinx In North Carolina (RTP). Opened a fancy new facility and a few years later was shut down. TB already has his retirement home ready to go in Montana, and once he is gone, so will be the San Diego operation.

    If LLY still exists in 5 years as an independent operation, I will be surprised.

    Sincerely,

    A former LRL employee
     
  8. Anonymous

    Anonymous Guest

    True facilities have been canned in the past but they were built and dedicated for single products. The new buzzword in the industry particularly when referring to biologicals is multi product. In other words the newer breed of facilities are being built with the anticipation of manufacturing any number of products and are not depending on merely one or two.

    So back to the original point about not building unless you will have products to manufacture I believe the company will bring any number of the new biologicals through the pipeline so to my mind the new facilities in Europe are safe......the US is a different matter.

    Take Ireland as an example......do any of you guys honestly believe lilly would be building new bio-manufacturing capacity there if A) the co doesn't believe it will have products for it to manufacture and B) They are building there merely for creative accounting purposes.
    We all know that the corporate tax rate in that country is a big incentive but all that is to my mind all the more reason to be confident that the company will bring new biologics to market.
    No reason to build there otherwise because you don't make corporate profits on thin air
     
  9. HR SHILL

    HR SHILL Guest

    HR SHILL

    What color is the sky in bldg. 74, and what drugs are you on?
     
  10. Anonymous

    Anonymous Guest

    Re: HR SHILL

    No not a HR shill & no drugs needed, rather I believe that Lilly will bounce back once the current period is worked through. This is because I am confident that the pipeline will come good and I see the biologics as pivotal in our recovery.

    Lilly will be here for many decades to come!!! The sky isn't falling in.
     
  11. Anonymous

    Anonymous Guest

    Re: HR SHILL

    Biologics for which indication?

    The antibodies don't merely NOT work, but often enough, kill the patient.

    The Imclone hype continues to swirl in some high places.

    First it was Martha Stewart, next it's LLY.
     
  12. Anonymous

    Anonymous Guest

    Re: HR SHILL

    The diabetes biologics for starters such as dula....closely followed by sola
    Then there's the RA antibody and not forgetting the oncology candidates in phase 2

    There is enough promise in those few pipeline drugs to give confidence....but that belief depends on an individuals own perspective. I remain assured by the depth and breadth of research the lilly is undertaking that it will bear fruit.
     
  13. Anonymous

    Anonymous Guest

    The whole antibody approach to clearing amyloid plaques is prima facie absurd for at least 2 reasons.

    1) If you hypothesize the antibody is crossing the bbb, and working in the brain....WHAT??? Anti-amyloid or amyloid fragment antibodies IN THE BRAIN? Nothing could possibly go wrong there, right???

    2) If you accept the antibodies work outside of the CNS compartment and somehow "shifts the solubility equilibrium" such that they are cleared that way, well HELLO....these plaques are frickin' INSOLUBLE! What sort of massively high antibody titer would be required to effect this? Look at your high school chemistry kids--you know, Le Châtelier's principle.

    IT IS DOOMED. BILLIONS DOWN THE DRAIN.
     
  14. Anonymous

    Anonymous Guest

    Re: HR SHILL

    Phase II? Really? How many things have died in late Ph.III or beyond? SPARE US the Pollyanna platitudes, you plasticized parrot. The sky is not falling: IT IS IGNITING, sending all of LLY, and those unfortunate enough to still be attached, into the ASH HEAP of pharmasaurs. "Pipeline" failure, after pipeline failure after FAILURE--there would have been a better return by forcing the cash into a commode, and waiting for the pressure to back up and spew up money from the bowl! Small molecule, large molecule--failure after failure after lie after lie. Look at the science fiction recited in any and ALL of the annual reports...LOOK AT THEM AND REMEMBER. WHAT HAS COME OF THIS PIPELINE--NOTHING! THERE IS NO "THERE" THERE!

    This December will drive that home. Facilities can be scrapped and liquidated for pennies-on-the-dollar to CMOs, at a moments notice due to "unexpected pipline attritition." This is the history of this place.
     
  15. Anonymous

    Anonymous Guest

    Look there are safety issues with any biologic. (You ever seen the list of possible side effects with some of the ones currently licensed? ) That is the nature of biotech as in many ways it is still an emerging technology. Remember that sola did show statistically significant data that it did slow progression in some of the clinical trials subjects. Now in a world which as yet has an unmet need for treating this disease I think it's worth waiting to see the results of the new trial before casting judgement.
     
  16. Anonymous

    Anonymous Guest

    Re: HR SHILL

    December is going to be the "bloodbath" we were told about in our town hall.
     
  17. Anonymous

    Anonymous Guest

    Lilly's a company that has run it's course. Sooner or later the board's best intentions will be trumped by the shareholder need to make money and Lilly will "merge" or be bought out. All the safeguards to keep Lilly in Indy won't matter when it happens. Will be a sad day for those of us who loved the company, although it's not the same place I respected anymore anyway. Hope I'm wrong and wishing everyone luck when/if it happens.
     
  18. Anonymous

    Anonymous Guest

    Re: HR SHILL

    Does anyone care to form a partnership to buy out some facilities and make a fortune in the generics space? Plenty of money in nutraceuticals too - and unlike many prescriptions, some of them work, without nasty side effects.
     
  19. Anonymous

    Anonymous Guest

    LLY has been an incredible destroyer of capital and value. The 5% year-over-year dividends are an unsustainable illusion. When they end, bye bye to everything. Don't be the "greater fool"--GET OUT NOW.

    There's a cash register
    Not ringing and
    it weighs so heavy on your back...
    YOU KNOW IT COULDN'T LAST!
     
  20. Anonymous

    Anonymous Guest

    No one is going to buy is- we have no short term pipeline and no current products that bring in significant revenue. If a company was going to try to buy us they would have did it around 2005 when Cymbalta was first coming out. Its been a steep downhill ride ever since then for our pipeline. Same reason why no one would merge with us. Use your head.